AnGes, Inc.
TSE:4563.T
Overview | Financials
Company Name | AnGes, Inc. |
Symbol | 4563.T |
Currency | JPY |
Price | 49 |
Market Cap | 12,586,602,805 |
Dividend Yield | 0% |
52-week-range | 43 - 98 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ei Yamada M.D., Ph.D. |
Website | https://www.anges.co.jp |
An error occurred while fetching data.
About AnGes, Inc.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD